Related Experiment Video
Updated: Jun 26, 2025

A 3D Organotypic Melanoma Spheroid Skin Model
Published on: May 18, 2018
Impairing hydrolase transport machinery prevents human melanoma metastasis
Alice Nordlinger1, Justine Del Rio1, Shivang Parikh2
1INSERM 1279, Tumor Cell Dynamics, Gustave Roussy, Université Paris-Saclay, Villejuif, France.
Abstract:
Metastases are the major cause of cancer-related death, yet, molecular weaknesses that could be exploited to prevent tumor cells spreading are poorly known. Here, we found that perturbing hydrolase transport to lysosomes by blocking either the expression of IGF2R, the main receptor responsible for their trafficking, or GNPT, a transferase involved in the addition of the specific tag recognized by IGF2R, reduces melanoma invasiveness potential. Mechanistically, we demonstrate that the perturbation of this traffic, leads to a compensatory lysosome neo-biogenesis devoided of degradative enzymes. This regulatory loop relies on the stimulation of TFEB transcription factor expression. Interestingly, the inhibition of this transcription factor playing a key role of lysosome production, restores melanomas' invasive potential in the absence of hydrolase transport. These data implicate that targeting hydrolase transport in melanoma could serve to develop new therapies aiming to prevent metastasis by triggering a physiological response stimulating TFEB expression in melanoma.
Insights
Blocking hydrolase transport to lysosomes reduces melanoma cell spread. This triggers a compensatory pathway involving TFEB, which, when inhibited, restores invasiveness, suggesting new anti-metastasis therapies.
Area of Science:
- Oncology
- Cell Biology
- Molecular Biology
Background:
- Metastasis is a leading cause of cancer mortality.
- Molecular targets to inhibit cancer cell spread are largely unknown.
Purpose of the Study:
- To investigate the role of hydrolase transport to lysosomes in melanoma invasiveness.
- To identify molecular mechanisms regulating melanoma cell spread.
Main Methods:
- Inhibition of IGF2R or GNPT to block hydrolase transport.
- Analysis of lysosome biogenesis and TFEB expression.
- Assessment of melanoma cell invasiveness.
Main Results:
- Blocking hydrolase transport via IGF2R or GNPT significantly reduced melanoma invasiveness.
- This blockage induced compensatory lysosome biogenesis lacking degradative enzymes.
- Inhibition of TFEB restored melanoma invasiveness, highlighting its role in this regulatory loop.
Conclusions:
- Targeting hydrolase transport to lysosomes is a potential therapeutic strategy to prevent melanoma metastasis.
- Stimulating TFEB expression via inhibiting hydrolase transport may offer a novel approach for anti-metastasis therapies.

